June 26, 2026 3-5pm ET

Friday on The Robert Scott Bell Show:




Hour 1

U.S. Supreme Court Ruling in Bayer Roundup Landmark Cancer Lawsuit The U.S. Supreme Court issued a significant ruling in a landmark case against Bayer (formerly Monsanto) regarding Roundup and its active ingredient glyphosate, potentially opening the door for thousands of cancer lawsuits to proceed by determining that federal pesticide regulations do not fully preempt state failure-to-warn claims brought by plaintiffs who allege the herbicide caused their non-Hodgkin lymphoma. The decision, closely watched by environmental, health, and agricultural groups, addresses whether EPA approval of glyphosate-based products shields the manufacturer from liability when patients claim the company failed to adequately warn about cancer risks despite internal documents and independent scientific assessments linking the chemical to increased cancer incidence. Bayer has faced over 160,000 claims since acquiring Monsanto, with previous multibillion-dollar settlements, but the company has argued that federal preemption should bar most state tort actions. The ruling is seen as a major victory for plaintiffs and those advocating for stronger corporate accountability on pesticides, while Bayer and agricultural industry groups warn it could lead to higher costs for farmers, reduced availability of essential herbicides, and a chilling effect on innovation in crop protection. Children’s Health Defense and other organizations hailed the decision as a step toward greater transparency on glyphosate’s health impacts, including potential contributions to chronic disease and environmental harm, while calling for continued independent research and policy changes to reduce reliance on synthetic chemicals in food production. The case underscores ongoing tensions between federal regulatory authority, state consumer protection laws, and corporate liability in the context of widespread pesticide use, with implications for future litigation involving other agricultural chemicals and the balance between agricultural productivity and public health protection. Legal experts note the ruling does not determine glyphosate’s carcinogenicity but clarifies the legal pathway for plaintiffs to seek compensation when they believe manufacturers withheld critical safety information. Bayer stated it would continue defending its products based on scientific evidence and regulatory approvals, while plaintiffs’ attorneys viewed the decision as validation of their claims and a signal that companies cannot hide behind federal approvals when state laws provide additional consumer safeguards. The development aligns with broader Make America Healthy Again efforts to scrutinize environmental toxins and their role in chronic disease, with advocates pushing for stricter oversight and reduced pesticide dependence in American agriculture.

Special Guest John Richardson

John A. Richardson, Jr., Founder and Chief Visionary Officer of Operation World Without Cancer and Founder of Richardson Nutritional Center, is the son of Dr. John A. Richardson, MD—a California physician who, in the 1970s, was raided, arrested, and ultimately stripped of his medical license for offering a natural cancer therapy known as Laetrile, or Vitamin B17, to more than six thousand patients. What began as a fight for his patients’ right to choose became a battle against government overreach, media smear campaigns, and the systemic suppression of natural healing alternatives. Today, John Jr. carries that mission forward—sharing the untold history, championing medical freedom, and shining a light on the many hidden natural treatments that offer hope in the fight against cancer. His goal: to help make a world without cancer not just a dream, but a reality.

 


Canada Drops Word ‘Injury’ From National Vaccine Injury Compensation Program The Canadian government has quietly removed the word “injury” from the official name of its national vaccine compensation program, rebranding it from the Vaccine Injury Support Program to the Vaccine Support Program in what critics describe as an attempt to downplay the reality of vaccine-related harms and reduce public awareness of adverse events following immunization. The change, implemented without public consultation or legislative debate, aligns with broader efforts by health authorities to soften language around vaccine safety while continuing to promote high vaccination rates across all age groups, including routine childhood schedules and annual flu and COVID boosters. Health Canada maintains the program still provides financial support for individuals who experience serious adverse events after vaccination, but the rebranding has drawn sharp criticism from medical freedom advocates, injured individuals, and researchers who argue it minimizes the severity of conditions such as myocarditis, Guillain-Barré syndrome, neurological disorders, and other documented reactions that have led to long-term disability or death in some cases. The program, originally launched to address rare but serious harms and maintain public confidence in immunization, has processed thousands of claims since its inception, yet approval rates remain low and compensation often falls short of covering lifelong medical needs. Opponents view the name change as part of a pattern of narrative management that includes restricted adverse event reporting, limited transparency on compensation data, and continued promotion of vaccines as unequivocally safe despite growing reports of excess mortality signals and chronic conditions in highly vaccinated populations. The development has fueled calls for greater accountability, independent safety reviews, and restoration of explicit acknowledgment of vaccine injuries to ensure informed consent and proper support for those harmed. Similar linguistic shifts have been observed in other countries as governments navigate declining public trust and increasing scrutiny of vaccine policies amid the Make America Healthy Again movement’s emphasis on transparency and root-cause approaches to chronic disease. Canadian officials have not provided detailed explanations for the rebranding, while advocacy groups plan to continue monitoring the program’s operations and pushing for meaningful reforms to better serve individuals experiencing post-vaccination complications.

Hour 2

Should Scientists Edit DNA in Human Embryos? Scientists and ethicists continue to debate the profound implications of editing DNA in human embryos using CRISPR and other gene-editing technologies, with proponents arguing it could eliminate devastating genetic diseases such as cystic fibrosis, Huntington’s, and certain forms of cancer before birth, while critics warn that the practice crosses ethical boundaries, risks unintended off-target mutations, permanent changes to the human germline that would be passed to future generations, and opens the door to designer babies and eugenics-style selection based on traits like intelligence, height, or appearance. The technology allows precise modification of embryos at the earliest stages, but safety concerns remain significant due to mosaicism, where not all cells receive the edit, and potential long-term effects that cannot be fully assessed in short clinical trials. International guidelines vary widely, with some countries banning germline editing outright while others permit limited research under strict oversight, creating a fragmented global landscape that raises the possibility of medical tourism and unregulated experimentation. Children’s Health Defense and bioethics advocates emphasize that altering the human genome represents a fundamental departure from natural reproduction and parental responsibility, potentially devaluing individuals with disabilities and shifting society toward a eugenic mindset where only “optimized” embryos are brought to term. Supporters counter that parents already make choices through prenatal screening and selective termination, and gene editing could prevent suffering more humanely. The debate intensified after the 2018 case of Chinese scientist He Jiankui, who edited embryos for HIV resistance, resulting in international condemnation and his imprisonment, yet subsequent research has quietly continued in laboratories worldwide. Experts call for robust international agreements, transparent public debate, and clear boundaries distinguishing therapeutic editing from enhancement, warning that without careful governance the technology could exacerbate social inequalities and fundamentally alter what it means to be human. The article underscores the need for caution, prioritizing long-term safety studies and ethical frameworks that respect human dignity over rapid commercialization or utopian promises of perfect children.

Chris Evert Reveals She Has Been Diagnosed with Ovarian Cancer for the Third Time Tennis legend Chris Evert announced on Instagram that her ovarian cancer has returned for the third time after an abnormal CT scan prompted exploratory surgery, with the 71-year-old stating she will begin chemotherapy in the coming weeks and step back from professional commitments to focus on her health while expressing optimism in continuing to fight the disease she described as relentless. Evert, who was first diagnosed with stage 1 ovarian cancer in 2021 — a year after her sister died from the disease — and announced a recurrence in late 2023 before entering remission, has long advocated for genetic testing and early detection after discovering she carries the BRCA gene and undergoing a preventive double mastectomy in 2022. She emphasized the importance of knowing one’s family history and acting promptly on any bodily changes, hoping her openness raises awareness and encourages others to prioritize health screenings. Longtime friend and fellow tennis icon Martina Navratilova publicly offered support, posting a photo of the two fist-bumping and expressing confidence that Evert would overcome the challenge again. Evert’s journey has been documented in the upcoming Netflix film Chris & Martina: The Final Set, which premieres June 26 and includes footage of her medical appointments and treatment experiences. The tennis champion, who has been candid about her battles, reiterated gratitude to her medical team, family, friends, and supporters while looking forward to returning to public life once treatment concludes. The announcement highlights the persistent nature of ovarian cancer and the critical role of ongoing vigilance even after successful prior treatments, as Evert continues to use her platform to promote awareness and early intervention for women facing similar diagnoses.

Younger Generations Are Aging Faster – and It May Be Fueling a Surge in Cancer A major new study from Washington University School of Medicine in St. Louis found that people born more recently tend to show signs of older biological age than earlier generations at the same chronological age, potentially helping explain the troubling rise in early-onset cancers diagnosed in people in their 20s, 30s, 40s, and early 50s. Researchers analyzed health data from more than 160,000 participants in the UK Biobank and All of Us Research Program, using measures such as PhenoAge, the Klemera-Doubal Method, and metabolomic age scores to assess systemic aging, along with organ-specific aging based on circulating proteins. The analysis revealed clear generational patterns, with individuals born between 1965 and 1974 in the UK and those born between 1990 and 1999 in the U.S. exhibiting higher levels of biological aging compared to earlier birth cohorts when evaluated at the same age. Greater systemic aging was associated with an 8% increase in the risk of early-onset solid cancers overall, rising to 15% for those with the highest levels of biological aging, with accelerated immune system aging linked to lung cancer and faster aging in adipose tissue associated with colorectal cancer. While the study cannot determine exact causes, researchers suspect cumulative effects from modern environments including diet, physical activity, sleep, stress, and environmental exposures may be accelerating biological aging and contributing to the increase in cancers traditionally associated with older age. The findings suggest biological aging could serve as a broad indicator of long-term health risk and offer a new framework for prevention by identifying at-risk individuals earlier through blood-based measures, enabling tailored interventions rather than broad recommendations. The study, published in Nature Medicine, emphasizes that cancer risk may be influenced by wider changes across the body as a whole rather than solely individual cellular changes, bringing researchers closer to decoding how modern environments become biologically embedded and supporting more personalized prevention strategies.

Report Highlights Disparate Burden of Cancer Across the United States A new report from the American Cancer Society reveals stark disparities in cancer incidence, mortality, and survival rates across the United States, with some states and demographic groups experiencing significantly higher burdens due to differences in risk factors, screening access, treatment availability, and socioeconomic conditions, underscoring the need for targeted public health interventions to address inequities that persist despite overall declines in cancer death rates nationwide. The analysis shows that states in the South and Midwest tend to have higher mortality rates for several major cancers including lung, colorectal, and cervical, while states with stronger screening programs and better healthcare infrastructure report lower death rates and higher survival, with factors such as smoking prevalence, obesity, limited access to preventive care, and delays in diagnosis playing major roles in these geographic differences. Racial and ethnic disparities remain pronounced, with Black Americans facing higher mortality rates for many cancers even when incidence is similar, largely attributable to systemic barriers in early detection and quality treatment, while rural populations experience worse outcomes due to distance from specialized cancer centers and lower insurance coverage. The report emphasizes that while overall cancer mortality has declined by more than 30 percent since 1991 thanks to reduced smoking, earlier detection, and improved therapies, progress has been uneven, with certain communities lagging far behind and bearing a disproportionate share of the disease burden. Experts recommend expanding access to screening programs, addressing social determinants of health, implementing culturally tailored prevention campaigns, and investing in rural healthcare infrastructure to close these gaps and ensure that advances in cancer care benefit all Americans regardless of where they live or their background. The findings align with broader discussions on health equity and the importance of precision public health strategies that account for local and demographic variations rather than relying solely on national averages. The American Cancer Society stressed that eliminating these disparities could prevent tens of thousands of preventable cancer deaths each year and called for policy changes to improve insurance coverage, reduce barriers to care, and support community-based prevention efforts across the country.



Remember Friends, The Power to Heal is Yours!



What would you like to hear from The Robert Scott Bell Show in 2025? Call us at 1-866-939-BELL (2355) and let your voice be heard!

Previous episodes of the Robert Scott Bell Show: SoundCloud

Learn the best ways to keep your family fed when the trucks have stopped, the stores shut down, and no food is available. Go to http://RSBFood.com